The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2025 | Evolving approaches for mediastinal nodal involvement in NSCLC
Paul van Schil, MD, PhD, University Hospital Antwerp, Antwerp, Belgium, comments on the evolving field of mediastinal nodal involvement in patients with lung cancer, highlighting the need for further research to determine the optimal management strategy for patients with persisting nodal involvement and one or two diseases. Whilst some surgeons agree that restaging the mediastinum is necessary to exclude patients with true disease, current evidence is not yet conclusive. This interview took place at the European Lung Cancer Congress (ELCC) 2025 in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
